-+ 0.00%
-+ 0.00%
-+ 0.00%

Atea Pharmaceuticals Q4 EPS $(0.57) Misses $(0.53) Estimate

Benzinga·03/05/2026 21:09:01
Listen to the news
Atea Pharmaceuticals (NASDAQ:AVIR) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0.53) by 7.55 percent. This is a 42.5 percent decrease over losses of $(0.40) per share from the same period last year.